Which has better valuation & earnings, ADUS or HNGE?

Addus HomeCare has higher revenue and earnings than Hinge Health. Addus HomeCare is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Addus HomeCare $1.42B 1.50 $95.91M $5.70 20.06 Hinge Health $587.86M 14.11 -$528.26M $1.28 80.33

Which has higher earnings & valuation, CHE or ADUS?

Chemed has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Chemed $2.53B 2.58 $265.24M $19.91 25.07 Addus HomeCare $1.42B 1.50 $95.91M $5.70 20.06

Is CHE or ADUS more profitable?

Chemed has a net margin of 10.60% compared to Addus HomeCare's net margin of 7.13%. Chemed's return on equity of 31.77% beat Addus HomeCare's return on equity. Company Net Margins Return on Equity Return on Assets Chemed 10.60% 31.77% 18.90% Addus HomeCare 7.13% 9.96% 7.62%

Which has preferable valuation and earnings, ADUS or BLLN?

Addus HomeCare has higher revenue and earnings than Billiontoone. Addus HomeCare is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Addus HomeCare $1.42B 1.50 $95.91M $5.70 20.06 Billiontoone $305.11M 15.17 $7.45M $0.70 140.13

Is ADUS or BLLN more profitable?

Billiontoone has a net margin of 8.04% compared to Addus HomeCare's net margin of 7.13%. Company Net Margins Return on Equity Return on Assets Addus HomeCare 7.13% 9.96% 7.62% Billiontoone 8.04% 9.96% 5.35%

Is RDNT or ADUS more profitable?

Addus HomeCare has a net margin of 7.13% compared to RadNet's net margin of -0.93%. Addus HomeCare's return on equity of 9.96% beat RadNet's return on equity. Company Net Margins Return on Equity Return on Assets RadNet -0.93% 2.61% 0.91% Addus HomeCare 7.13% 9.96% 7.62%

Addus HomeCare (ADUS) Competitors

$114.33 +0.07 (+0.06%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$114.41 +0.08 (+0.07%)

As of 10/9/2026 07:30 PM Eastern

Compare

ADUS vs. HNGE, HIMS, CHE, BLLN, and RDNT

Should you buy Addus HomeCare stock or one of its competitors? Addus HomeCare's main competitors and comparable companies include Hinge Health (HNGE), Hims & Hers Health (HIMS), Chemed (CHE), Billiontoone (BLLN), and RadNet (RDNT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Addus HomeCare compare to Hinge Health?

Addus HomeCare (NASDAQ:ADUS) and Hinge Health (NYSE:HNGE) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

95.4% of Addus HomeCare shares are owned by institutional investors. 4.1% of Addus HomeCare shares are owned by company insiders. Comparatively, 18.9% of Hinge Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Hinge Health has a net margin of 15.15% compared to Addus HomeCare's net margin of 7.13%. Hinge Health's return on equity of 51.60% beat Addus HomeCare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	7.13%	9.96%	7.62%
Hinge Health	15.15%	51.60%	14.16%

In the previous week, Hinge Health had 10 more articles in the media than Addus HomeCare. MarketBeat recorded 11 mentions for Hinge Health and 1 mentions for Addus HomeCare. Hinge Health's average media sentiment score of 0.44 beat Addus HomeCare's score of -0.20 indicating that Hinge Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Addus HomeCare	Neutral
Hinge Health	Neutral

Addus HomeCare has higher revenue and earnings than Hinge Health. Addus HomeCare is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42B	1.50	$95.91M	$5.70	20.06
Hinge Health	$587.86M	14.11	-$528.26M	$1.28	80.33

Addus HomeCare presently has a consensus price target of $129.33, indicating a potential upside of 13.12%. Hinge Health has a consensus price target of $105.33, indicating a potential upside of 2.44%. Given Addus HomeCare's higher possible upside, equities analysts clearly believe Addus HomeCare is more favorable than Hinge Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55
Hinge Health	0 Sell rating(s)	3 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.89

Addus HomeCare has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.37, suggesting that its share price is 37% more volatile than the broader market.

Summary

Hinge Health beats Addus HomeCare on 11 of the 16 factors compared between the two stocks.

How does Addus HomeCare compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, media sentiment and valuation.

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by company insiders. Comparatively, 4.1% of Addus HomeCare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Hims & Hers Health had 31 more articles in the media than Addus HomeCare. MarketBeat recorded 32 mentions for Hims & Hers Health and 1 mentions for Addus HomeCare. Hims & Hers Health's average media sentiment score of 0.12 beat Addus HomeCare's score of -0.20 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company	Overall Sentiment
Hims & Hers Health	Neutral
Addus HomeCare	Neutral

Hims & Hers Health currently has a consensus price target of $32.43, suggesting a potential upside of 5.08%. Addus HomeCare has a consensus price target of $129.33, suggesting a potential upside of 13.12%. Given Addus HomeCare's stronger consensus rating and higher possible upside, analysts clearly believe Addus HomeCare is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13
Addus HomeCare	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55

Hims & Hers Health has a beta of 2.44, indicating that its stock price is 144% more volatile than the broader market. Comparatively, Addus HomeCare has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market.

Addus HomeCare has a net margin of 7.13% compared to Hims & Hers Health's net margin of -5.51%. Addus HomeCare's return on equity of 9.96% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Addus HomeCare	7.13%	9.96%	7.62%

Hims & Hers Health has higher revenue and earnings than Addus HomeCare. Hims & Hers Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	3.07	$128.37M	-$0.63	N/A
Addus HomeCare	$1.42B	1.50	$95.91M	$5.70	20.06

Summary

Addus HomeCare beats Hims & Hers Health on 10 of the 17 factors compared between the two stocks.

How does Addus HomeCare compare to Chemed?

Chemed (NYSE:CHE) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

Chemed has a beta of 0.51, suggesting that its share price is 49% less volatile than the broader market. Comparatively, Addus HomeCare has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market.

Chemed has a net margin of 10.60% compared to Addus HomeCare's net margin of 7.13%. Chemed's return on equity of 31.77% beat Addus HomeCare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemed	10.60%	31.77%	18.90%
Addus HomeCare	7.13%	9.96%	7.62%

In the previous week, Chemed had 5 more articles in the media than Addus HomeCare. MarketBeat recorded 6 mentions for Chemed and 1 mentions for Addus HomeCare. Chemed's average media sentiment score of 0.15 beat Addus HomeCare's score of -0.20 indicating that Chemed is being referred to more favorably in the media.

Company	Overall Sentiment
Chemed	Neutral
Addus HomeCare	Neutral

Chemed currently has a consensus target price of $554.60, indicating a potential upside of 11.11%. Addus HomeCare has a consensus target price of $129.33, indicating a potential upside of 13.12%. Given Addus HomeCare's stronger consensus rating and higher possible upside, analysts plainly believe Addus HomeCare is more favorable than Chemed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemed	0 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.29
Addus HomeCare	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55

95.9% of Chemed shares are held by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are held by institutional investors. 3.3% of Chemed shares are held by insiders. Comparatively, 4.1% of Addus HomeCare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Chemed has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemed	$2.53B	2.58	$265.24M	$19.91	25.07
Addus HomeCare	$1.42B	1.50	$95.91M	$5.70	20.06

Summary

Chemed beats Addus HomeCare on 11 of the 17 factors compared between the two stocks.

How does Addus HomeCare compare to Billiontoone?

Addus HomeCare (NASDAQ:ADUS) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

Addus HomeCare has higher revenue and earnings than Billiontoone. Addus HomeCare is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42B	1.50	$95.91M	$5.70	20.06
Billiontoone	$305.11M	15.17	$7.45M	$0.70	140.13

In the previous week, Billiontoone had 12 more articles in the media than Addus HomeCare. MarketBeat recorded 13 mentions for Billiontoone and 1 mentions for Addus HomeCare. Billiontoone's average media sentiment score of 0.11 beat Addus HomeCare's score of -0.20 indicating that Billiontoone is being referred to more favorably in the news media.

Company	Overall Sentiment
Addus HomeCare	Neutral
Billiontoone	Neutral

Addus HomeCare presently has a consensus target price of $129.33, suggesting a potential upside of 13.12%. Billiontoone has a consensus target price of $126.25, suggesting a potential upside of 28.71%. Given Billiontoone's higher probable upside, analysts plainly believe Billiontoone is more favorable than Addus HomeCare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.55

95.4% of Addus HomeCare shares are owned by institutional investors. 4.1% of Addus HomeCare shares are owned by company insiders. Comparatively, 50.2% of Billiontoone shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Billiontoone has a net margin of 8.04% compared to Addus HomeCare's net margin of 7.13%.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	7.13%	9.96%	7.62%
Billiontoone	8.04%	9.96%	5.35%

Summary

Billiontoone beats Addus HomeCare on 8 of the 14 factors compared between the two stocks.

How does Addus HomeCare compare to RadNet?

RadNet (NASDAQ:RDNT) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, media sentiment, institutional ownership, earnings, dividends and profitability.

77.9% of RadNet shares are held by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are held by institutional investors. 5.1% of RadNet shares are held by company insiders. Comparatively, 4.1% of Addus HomeCare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

RadNet has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market. Comparatively, Addus HomeCare has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market.

RadNet currently has a consensus price target of $90.00, indicating a potential upside of 26.92%. Addus HomeCare has a consensus price target of $129.33, indicating a potential upside of 13.12%. Given RadNet's stronger consensus rating and higher possible upside, equities analysts plainly believe RadNet is more favorable than Addus HomeCare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89
Addus HomeCare	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55

Addus HomeCare has a net margin of 7.13% compared to RadNet's net margin of -0.93%. Addus HomeCare's return on equity of 9.96% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.93%	2.61%	0.91%
Addus HomeCare	7.13%	9.96%	7.62%

In the previous week, RadNet had 2 more articles in the media than Addus HomeCare. MarketBeat recorded 3 mentions for RadNet and 1 mentions for Addus HomeCare. RadNet's average media sentiment score of 0.58 beat Addus HomeCare's score of -0.20 indicating that RadNet is being referred to more favorably in the media.

Company	Overall Sentiment
RadNet	Positive
Addus HomeCare	Neutral

Addus HomeCare has lower revenue, but higher earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.27B	2.46	-$18.65M	-$0.27	N/A
Addus HomeCare	$1.42B	1.50	$95.91M	$5.70	20.06

Summary

RadNet beats Addus HomeCare on 9 of the 16 factors compared between the two stocks.

Get Addus HomeCare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ADUS vs. The Competition

Export

Metric	Addus HomeCare	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.13B	$9.81B	$7.16B	$13.21B
Dividend Yield	N/A	2.61%	2.53%	16.37%
P/E Ratio	20.06	33.98	274.15	26.16
Price / Sales	1.50	4.87	635.98	113.06
Price / Cash	17.59	115.75	76.38	53.09
Price / Book	1.95	5.11	11.21	6.34
Net Income	$95.91M	$315.68M	$3.50B	$381.90M
7 Day Performance	2.75%	-0.38%	-0.90%	-1.41%
1 Month Performance	-3.54%	-1.97%	-4.44%	-3.48%
1 Year Performance	1.26%	12.76%	6.96%	1.16%

Addus HomeCare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ADUS Addus HomeCare	2.887 of 5 stars	$114.33 +0.1%	$129.33 +13.1%	0.0%	$2.13B	$1.42B	20.06	50,659
HNGE Hinge Health	2.5474 of 5 stars	$92.01 -0.5%	$104.13 +13.2%	+103.8%	$7.43B	$587.86M	71.89	1,437	Analyst Downgrade Insider Trade
HIMS Hims & Hers Health	1.754 of 5 stars	$28.84 +0.2%	$32.43 +12.4%	-46.9%	$6.71B	$2.35B	N/A	2,442	Trending News Gap Up
CHE Chemed	4.4513 of 5 stars	$511.39 -0.6%	$554.60 +8.4%	+15.8%	$6.68B	$2.53B	25.69	15,811	News Coverage Analyst Upgrade
BLLN Billiontoone	4.1433 of 5 stars	$121.42 -0.2%	$125.88 +3.7%	N/A	$5.73B	$305.11M	173.45	713	Analyst Downgrade Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ADUS) was last updated on 10/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Addus HomeCare (ADUS) Competitors

ADUS vs. HNGE, HIMS, CHE, BLLN, and RDNT

How does Addus HomeCare compare to Hinge Health?

Summary

How does Addus HomeCare compare to Hims & Hers Health?

Summary

How does Addus HomeCare compare to Chemed?

Summary

How does Addus HomeCare compare to Billiontoone?

Summary

How does Addus HomeCare compare to RadNet?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADUS vs. The Competition

Addus HomeCare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Addus HomeCare (ADUS) Competitors

ADUS vs. HNGE, HIMS, CHE, BLLN, and RDNT

How does Addus HomeCare compare to Hinge Health?

Do insiders and institutionals believe in ADUS or HNGE?

Is ADUS or HNGE more profitable?

Does the media prefer ADUS or HNGE?

Which has better valuation & earnings, ADUS or HNGE?

Do analysts prefer ADUS or HNGE?

Which has more volatility and risk, ADUS or HNGE?

Summary

How does Addus HomeCare compare to Hims & Hers Health?

Do insiders and institutionals have more ownership in HIMS or ADUS?

Does the media favor HIMS or ADUS?

Do analysts prefer HIMS or ADUS?

Which has more risk & volatility, HIMS or ADUS?

Is HIMS or ADUS more profitable?

Which has better earnings & valuation, HIMS or ADUS?

Summary

How does Addus HomeCare compare to Chemed?

Which has more volatility and risk, CHE or ADUS?

Is CHE or ADUS more profitable?

Does the media refer more to CHE or ADUS?

Do analysts prefer CHE or ADUS?

Do insiders and institutionals believe in CHE or ADUS?

Which has higher earnings & valuation, CHE or ADUS?

Summary

How does Addus HomeCare compare to Billiontoone?

Which has preferable valuation and earnings, ADUS or BLLN?

Does the media favor ADUS or BLLN?

Do analysts prefer ADUS or BLLN?

Do institutionals & insiders hold more shares of ADUS or BLLN?

Is ADUS or BLLN more profitable?

Summary

How does Addus HomeCare compare to RadNet?

Do insiders and institutionals believe in RDNT or ADUS?

Which has more risk and volatility, RDNT or ADUS?

Do analysts recommend RDNT or ADUS?

Is RDNT or ADUS more profitable?

Does the media prefer RDNT or ADUS?

Which has higher valuation & earnings, RDNT or ADUS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADUS vs. The Competition

Addus HomeCare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools